A single-nucleotide polymorphism (rs8176070) of lncRNAPART1 may reflect the risk for knee osteoarthritis

References (1)

1. Diab SM, Kamal HM, Mansour AI, Fawzy RM, Azab BS. Clinical significance of Matrilin-3 gene polymorphism in Egyptian patients with primary knee osteoarthritis. Eur J Rheumatol 2017; 4: 200-4. [Crossref] 2. Gu J, Rong J, Guan F, Jiang L, Tao S, Guan G, et al. MATN3 gene polymorphism is associated with osteoarthritis in Chinese Han population: A community-based case-control study. ScientificWorldJournal 2012; 656084. [Crossref] 3. Stefánsson SE, Jónsson H, Ingvarsson T, Manolescu I, Jónsson HH, Olafsdóttir G, et al. Genomewide scan for hand osteoarthritis: A novel mutation in matrilin-3. Am J Hum Genet 2003; 72: 1448-59. [Crossref] 4. Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, et al. Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. Ann Rheum Dis 2006; 65: 1060-6. [Crossref] 5. Pullig O, Tagariello A, Schweizer A, Swoboda B, Schaller P, Winterpacht A. MATN3 (matrilin-3) sequence variation (pT303M) is a risk factor for osteoarthritis of the CMC1 joint of the hand, but not for knee osteoarthritis. Ann Rheum Dis 2007; 66: 279-80. [Crossref] 6. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12: 996- 1006. [Crossref] 7. Zhu Y-J, Jiang D-M. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis. Eur Rev Med Pharmacol Sci 2019; 23: 8175-85.